CARMOL Drug Patent Profile
✉ Email this page to a colleague
When do Carmol patents expire, and when can generic versions of Carmol launch?
Carmol is a drug marketed by Fougera Pharms and is included in one NDA.
The generic ingredient in CARMOL is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CARMOL?
- What are the global sales for CARMOL?
- What is Average Wholesale Price for CARMOL?
Summary for CARMOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CARMOL at DailyMed |
US Patents and Regulatory Information for CARMOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | CARMOL HC | hydrocortisone acetate | CREAM;TOPICAL | 080505-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
